| MGMT status as a clinical biomarker in glioblastoma M Butler, L Pongor, YT Su, L Xi, M Raffeld, M Quezado, J Trepel, K Aldape, ... Trends in cancer 6 (5), 380-391, 2020 | 163 | 2020 |
| TPMCalculator: one-step software to quantify mRNA abundance of genomic features R Vera Alvarez, LS Pongor, L Mariño-Ramírez, D Landsman Bioinformatics 35 (11), 1960-1962, 2019 | 145 | 2019 |
| A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients L Pongor, M Kormos, C Hatzis, L Pusztai, A Szabó, B Győrffy Genome medicine 7, 1-11, 2015 | 122 | 2015 |
| Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer DK Patten, G Corleone, B Győrffy, Y Perone, N Slaven, I Barozzi, E Erdős, ... Nature Medicine 24 (9), 1469-1480, 2018 | 120 | 2018 |
| SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures C Tlemsani, L Pongor, F Elloumi, L Girard, KE Huffman, N Roper, ... Cell reports 33 (3), 2020 | 96 | 2020 |
| Wanted DEAD/H or alive: helicases winding up in cancers W Cai, Z Xiong Chen, G Rane, S Satendra Singh, Z Choo, C Wang, ... JNCI: Journal of the National Cancer Institute 109 (6), djw278, 2017 | 94 | 2017 |
| Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis T Jiang, W Shi, VB Wali, LS Pongor, C Li, R Lau, B Győrffy, RP Lifton, ... PLoS medicine 13 (12), e1002193, 2016 | 91 | 2016 |
| TP53 mutation hits energy metabolism and increases glycolysis in breast cancer H Harami-Papp, LS Pongor, G Munkácsy, G Horváth, ÁM Nagy, A Ambrus, ... Oncotarget 7 (41), 67183, 2016 | 56 | 2016 |
| Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress J Murai, H Zhang, L Pongor, SW Tang, U Jo, F Moribe, Y Ma, M Tomita, ... Cell reports 30 (12), 4137-4151. e6, 2020 | 53 | 2020 |
| A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells XL Li, L Pongor, W Tang, S Das, BR Muys, MF Jones, SB Lazar, ... Elife 9, e53734, 2020 | 52 | 2020 |
| Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies C Tlemsani, N Takahashi, L Pongor, VN Rajapakse, M Tyagi, X Wen, ... Science translational medicine 13 (578), eabc7488, 2021 | 44 | 2021 |
| KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer Á Nagy, LS Pongor, A Szabó, M Santarpia, B Győrffy International journal of cancer 140 (4), 930-937, 2017 | 41 | 2017 |
| BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks LS Pongor, JM Gross, R Vera Alvarez, J Murai, SM Jang, H Zhang, ... Epigenetics & chromatin 13, 1-13, 2020 | 39 | 2020 |
| Mutations defining patient cohorts with elevated PD-L1 expression in gastric cancer O Menyhárt, LS Pongor, B Győrffy Frontiers in Pharmacology 9, 430580, 2019 | 33 | 2019 |
| The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma BR Muys, DG Anastasakis, D Claypool, L Pongor, XL Li, I Grammatikakis, ... Genes & Development 35 (1-2), 102-116, 2021 | 32 | 2021 |
| DNA and RNA cleavage complexes and repair pathway for TOP3B RNA-and DNA-protein crosslinks S Saha, Y Sun, SN Huang, SA Baechler, LS Pongor, K Agama, U Jo, ... Cell reports 33 (13), 2020 | 28 | 2020 |
| Dynamics of replication origin over-activation H Fu, CE Redon, BL Thakur, K Utani, R Sebastian, SM Jang, JM Gross, ... Nature Communications 12 (1), 3448, 2021 | 27 | 2021 |
| An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes B Győrffy, L Pongor, G Bottai, X Li, J Budczies, A Szabó, C Hatzis, ... British Journal of Cancer 118 (8), 1107-1114, 2018 | 24 | 2018 |
| The RepID–CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation SM Jang, JF Nathans, H Fu, CE Redon, LM Jenkins, BL Thakur, ... Nature Communications 11 (1), 24, 2020 | 22 | 2020 |
| Uncovering potential therapeutic targets in colorectal cancer by deciphering mutational status and expression of druggable oncogenes O Menyhart, T Kakisaka, LS Pongor, H Uetake, A Goel, B Győrffy Cancers 11 (7), 983, 2019 | 22 | 2019 |
Balázs GyőrffyClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of SciencesVerified email at ttk.mta.hu
